Yarrow Bioscience is a New Haven biopharmaceutical company developing drugs for inflammatory and immune conditions. It last closed at $12.90 on Nov 20, down 9.35% on the day. The next earnings report for YARW is expected around Thu, Feb 11, 2027. For the quarter ended Sep 2026, YARW reported EPS of -$0.43.
AI Auto Pilots
Is YARW in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold YARW.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on YARWStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
YARW · as of the Nov 20 close · updated each morning
Falling, nearing oversold
The stock is 30% below its 20 day and 58% below its 50 day average. Momentum is weak (RSI 35), near oversold. The nearest support is the 52 week low at $12.38, and the nearest resistance the Pivot at $13.38.
Short trendBearish
Long trendNot enough history
MomentumWeak
StretchNear oversold
VolatilityHigh, 17.9%/day
Key levels
$44.2852 week high+243.3%
$20.3950 day average+58.1%
$19.92Swing high (Nov 12)+54.4%
$16.8320 day average+30.5%
$14.11Pivot R1+9.4%
$13.38Pivot+3.7%
$12.90Last close
$12.3852 week low−4.0%
$12.38Swing low (Nov 5)−4.0%
$12.16Pivot S1−5.7%
Indicators
RSI (14)
34.61
Weak, oversold below 30
Neutral
MACD
-1.89
Below its signal line
Bearish
Stochastic
17.6
Near the bottom of its range
Oversold
ADX (14)
37.9
Trending down
Williams %R
-93.2
Oversold below −80, overbought above −20
Oversold
CCI (20)
-117.9
Oversold below −100, overbought above 100
Oversold
Rate of change
−17.3%
Change over 10 sessions
Bearish
ATR (14)
$2.30
Typical daily range, 17.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100–
MA 200–
What happened before, for YARW
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how YARW did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow YARW usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for YARWHow many large options trades hit YARW, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in YARW in the last 90 days.
From SEC Form 4 filings by YARW's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether YARW is in one of them and how their past YARW trades turned out.
Yarrow Bioscience is a biopharmaceutical company based in New Haven, Connecticut, that develops treatments for inflammatory and immune conditions. Its work centers on BET inhibitors, a class of small molecule drugs that aim to calm overactive inflammatory signaling in the body. Its candidates are still in clinical testing and have not been approved for sale. The company's planned focus is on Graves disease and Thyroid Eye Disease, with patients and their treating doctors as the intended users of any approved treatment.